PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 26, 2003New England Journal of Medicine3,186 citationsOpen Access

Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

View Full Paper
AFArlene A. ForastiereHGHelmuth GoepfertMMMoshe Maor

Key Points

  • This research aims to evaluate the efficacy of concurrent chemotherapy and radiotherapy for laryngeal cancer preservation.
  • Conducted a randomized trial comparing concurrent cisplatin with radiotherapy to induction chemotherapy followed by radiotherapy and radiotherapy alone.
  • Included patients with advanced laryngeal cancer.
  • Concurrent radiotherapy with cisplatin demonstrated superior laryngeal preservation compared to induction chemotherapy followed by radiotherapy and radiotherapy alone, with significant locoregional control.

Abstract

In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Forastiere et al. (2003) studied this question.

synapsesocial.com/papers/69dabd63a6045d71bfa3e01bhttps://doi.org/10.1056/nejmoa031317
Ask AI
Helpful
Bookmark
Share
View Full Paper